Polypharmacy and health related quality of life among older adults on antiretroviral therapy in a tertiary hospital in Tanzania: a hospital-based cross-sectional study | BMC Infectious Diseases
Residual Income

Polypharmacy and well being associated high quality of life amongst older adults on antiretroviral remedy in a tertiary hospital in Tanzania: a hospital-based cross-sectional examine | BMC Infectious Ailments

  • Sheet F, Hiv N, Hiv N. World HIV statistics. 2022. p. 1–6.

    Google Scholar 

  • AVERT World info and schooling on HIV and AIDS. HIV and AIDS in Key affected populations. 2017; Accessible from: https://www.avert.org/professionals/hiv-around-world/asia-pacific/india#footnote2_7i7ga58

  • Monitoring GA. 2020 Progress studies submitted by international locations – United Republic of Tanzania. 2020; Accessible from: https://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2020countries

  • Swai SJ, Damian DJ, Urassa S, Temba B, Mahande MJ, Philemon RN, et al. Prevalence and threat elements for HIV amongst individuals aged 50 years and older in Rombo district. Northern Tanzania Tanzan J Well being Res. 2017;19(2):1–8.

    Google Scholar 

  • ZelekeNegera G, Ayele MT. Well being-related high quality of life amongst admitted HIV/AIDS sufferers in chosen ethiopian tertiary care settings: a cross-sectional examine. Open Public Well being J. 2020;12(1):532–40.

    Article 

    Google Scholar 

  • Effros RB, Fletcher CV, Gebo Okay, Halter JB, Hazzard WR, Horne FMF, et al. Workshop on HIV an infection and getting older: What is thought and future analysis instructions. Clin Infect Dis. 2008;47(4):542–53.

    Article 
    PubMed 

    Google Scholar 

  • Manuscript A. Life expectancy of people on mixture antiretroviral remedy in high-income international locations: a collaborative evaluation of 14 cohort research. Lancet. 2008;372(9635):293–9.

    Article 

    Google Scholar 

  • Krentz HB, Cosman I, Lee Okay, Ming JM, Gill MJ. Unique article Tablet burden in HIV an infection : 20 years of expertise. Antivir Ther. 2012;840:833–40.

    Article 

    Google Scholar 

  • de Gaetano Donati Okay, Cauda R, Iacoviello L. HIV an infection, antiretroviral remedy and cardiovascular threat. Mediterr J Hematol Infect Dis. 2010;2(3):e2010034.

    Article 

    Google Scholar 

  • Defo AK, Chalati MD, Labos C, Fellows LK, Mayo NE, Daskalopoulou SS. Affiliation of HIV an infection and antiretroviral remedy with arterial stiffness: a scientific evaluate and meta-analysis. Hypertension. 2021;78(2):320–32.

    Article 

    Google Scholar 

  • Cerrato E, D’Ascenzo F, Biondi-Zoccai G, Calcagno A, Frea S, Grosso Marra W, et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus sufferers: a meta-analysis within the extremely energetic antiretroviral remedy period. Eur Coronary heart J. 2013;34(19):1432–6.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Islam FM, Wu J, Jansson J, Wilson DP. Relative threat of renal illness amongst individuals residing with HIV: a scientific evaluate and meta-analysis. BMC Public Well being. 2012;12(1):234. Accessible from: http://www.biomedcentral.com/1471-2458/12/234

  • Chawla A, Wang C, Patton C, Murray M. A evaluate of long-term toxicity of antiretroviral therapy regimens and implications for an getting older inhabitants. Infect Dis Ther. 2018;7(2):183–95. https://doi.org/10.1007/s40121-018-0201-6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Mtisi TJ, Ndhlovu CE, Maponga CC, Morse GD. Tenofovir-associated kidney illness in Africans: A scientific evaluate. AIDS Res Ther. 2019;16(1):1–16. https://doi.org/10.1186/s12981-019-0227-1.

    Article 
    CAS 

    Google Scholar 

  • Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Niño MD, Izquierdo MC, Poveda J, et al. Tenofovir nephrotoxicity: 2011 replace. AIDS Res Deal with. 2011;2011:354908. https://doi.org/10.1155/2011/354908.

  • World Well being Group. Remedy security in polypharmacy. 2019;1–63. Accessible from: https://apps.who.int/iris/bitstream/deal with/10665/325454/WHO-UHC-SDS-2019.11-eng.pdf?sequence=1&isAllowed=y

  • Ware D, Palella FJ, Chew KW, Reuel Friedman M, D’Souza G, Ho Okay, et al. Prevalence and developments of polypharmacy amongst HIV-positive and -negative males within the Multicenter AIDS Cohort Research from 2004 to 2016. PLoS ONE. 2018;13(9):1–14.

    Article 

    Google Scholar 

  • Gibbs A, Reddy T, Dunkle Okay, Jewkes R. HIV-Prevalence in South Africa by settlement kind: a repeat population-based cross-sectional evaluation of women and men. PLoS One. 2020;15(3):1–20. https://doi.org/10.1371/journal.pone.0230105.

    Article 
    CAS 

    Google Scholar 

  • Ssonko M, Stanaway F, Mayanja HK, et al. Polypharmacy amongst HIV optimistic older adults on anti-retroviral remedy attending an city clinic in Uganda. BMC Geriatr. 2018;18:125. https://doi.org/10.1186/s12877-018-0817-0.

  • Moore HN, Mao L, Oramasionwu CU. Components related to polypharmacy and the prescription of a number of drugs amongst individuals residing with HIV (PLWH) in comparison with non-PLWH. AIDS Care – Psychol Socio-Medical Asp AIDS/HIV. 2015;27(12):1443–8.

    Article 

    Google Scholar 

  • Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and getting older in HIV-infected individuals: the swiss HIV cohort examine. Clin Infect Dis. 2011;53(11):1130–9.

    Article 
    PubMed 

    Google Scholar 

  • Justice AC, Gordon KS, Skanderson M, Edelman EJ, Akgün KM, Gibert CL, et al. Nonantiretroviral polypharmacy and hostile well being outcomes amongst HIV-infected and uninfected people. AIDS. 2018;32(6):739–49.

    Article 
    PubMed 

    Google Scholar 

  • Wing EJ. Worldwide Journal of Infectious Ailments HIV and getting older. 2016;53:61–8. https://doi.org/10.1016/j.ijid.2016.10.004.

  • Siefried KJ, Mao L, Cysique LA, Rule J, Giles ML, Smith DE, et al. Concomitant medicine polypharmacy, interactions and imperfect adherence are frequent in Australian adults on suppressive antiretroviral remedy. Aids. 2018;32:35–48.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Schlaeppi C, Vanobberghen F, Sikalengo G, Glass TR, Ndege RC, Foe G, et al. Prevalence and administration of drug–drug interactions with antiretroviral therapy in 2069 individuals residing with HIV in rural Tanzania: a potential cohort examine. HIV Med. 2020;21(1):53–63.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Dube MP. , Stein JH. AJ. Panel on Antiretroviral Tips for Adults and Adolescents. Tips for the Use of Antiretroviral Brokers in Adults and Adolescents with HIV. Dep Heal Hum Serv. 2021;40(Construct 29393). Accessible from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

  • Courlet P, Livio F, Guidi M, Cavassini M, Battegay M, Stoeckle M, Buclin T, Alves Saldanha S, Csajka C, Marzolini C, Decosterd L; Swiss HIV Cohort Research. Polypharmacy, Drug-Drug Interactions, and Inappropriate Medicine: New Challenges within the Growing older Inhabitants With HIV. Open Discussion board Infect Dis. 2019;6(12):ofz531. https://doi.org/10.1093/ofid/ofz531.

  • DerSarkissian M, Bhak RH, Oglesby A, Priest J, Gao E, Macheca M, et al. Retrospective evaluation of comorbidities and therapy burden amongst sufferers with HIV an infection in a US Medicaid inhabitants. Curr Med Res Opin. 2020;36(5):781–8. https://doi.org/10.1080/03007995.2020.1716706.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Greene M, Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug-drug interactions, and doubtlessly inappropriate drugs in older adults with human immunodeficiency virus an infection. J Am Geriatr Soc. 2014;62(3):447–53.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Greene M, Justice AC, Lampiris HW, Valcour V. Administration of HIV in superior age. JAMA – J Am Med Assoc. 2013;309(13):1–20.

    Google Scholar 

  • Krentz HB, Gill MJ. The impression of non-antiretroviral polypharmacy on the continuity of antiretroviral remedy (ART) amongst HIV sufferers. AIDS Affected person Care STDS. 2016;30(1):11–7.

    Article 
    PubMed 

    Google Scholar 

  • Okoli C, de Los RP, Eremin A, Brough G, Younger B, Quick D. Relationship between polypharmacy and high quality of life amongst individuals in 24 international locations residing with HIV. Prev Continual Dis. 2020;17:E22.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Passos SMK, Souza LD de M. An analysis of high quality of life and its determinants amongst individuals residing with HIV/AIDS from Southern Brazil. Cad Saude Publica. 2015;31(4):800–14.

  • Monteiro F, Canavarro MC, Pereira M. Components related to high quality of life in middle- aged and older sufferers residing with HIV with HIV. AIDS Care. 2016;0(0):1–7. https://doi.org/10.1080/09540121.2016.1146209

  • Smith JM, Flexner C. The problem of polypharmacy in an getting older inhabitants and implications for future antiretroviral remedy improvement. AIDS. 2017;31(January):S173–84.

    Article 
    PubMed 

    Google Scholar 

  • Morillo-Verdugo R, Robustillo-Cortés MDLA, Martín LAK, De Sotomayor Paz MÁ, De León Naranjo FL, Almeida-González CV. Dedication of a cutoff worth for medicine routine complexity index to foretell polypharmacy in HIV+ older affected person. Rev Esp Quimioter. 2019;32(5):458–64.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cañabate SF, Valín LO. Polypharmacy amongst HIV contaminated individuals aged 50 years or older. Colomb Med. 2019;50(3):142–52.

    Article 

    Google Scholar 

  • López-Centeno B, Badenes-Olmedo C, Mataix-Sanjuan Á, McAllister Okay, Bellón JM, Gibbons S, et al. Polypharmacy and Drug-Drug Interactions in Folks Dwelling With Human Immunodeficiency Virus within the Area of Madrid, Spain: A Inhabitants-Based mostly Research. Clin Infect Dis. 2020;71(2):353–62. https://doi.org/10.1093/cid/ciz811.

  • Kong AM, Pozen A, Anastos Okay, Kelvin EA, Nash D. Non-HIV comorbid circumstances and polypharmacy amongst individuals residing with HIV age 65 or older in contrast with HIV-negative people age 65 or older in the US: a retrospective claims-based evaluation. AIDS Affected person Care STDS. 2019;33(3):93–103.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Hovstadius B, Petersson G. Components Resulting in Extreme Polypharmacy. Clin Geriatr Med. 2012;28(2):159–72. https://doi.org/10.1016/j.cger.2012.01.001.

    Article 
    PubMed 

    Google Scholar 

  • Marzolini C, Elzi L, Gibbons S, Weber R, Fux C, Furrer H, et al. Prevalence of comedications and impact of potential drug-drug interactions within the Swiss HIV cohort examine. Antivir Ther. 2010;15(3):413–23.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kara E, İnkaya AÇ, Hakli DA, Demirkan Okay, Ünal S. Polypharmacy and drug-related issues amongst individuals residing with HIV/aids: a single-center expertise. Turkish J Med Sci. 2019;49(1):222–9.

    Google Scholar 

  • Mata-Marín JA, Martínez-Osio MH, Arroyo-Anduiza CI, Berrospe-Silva MDLÁ, Chaparro-Sánchez A, Cruz-Grajales I, et al. Comorbidities and polypharmacy amongst HIV-positive sufferers aged 50 years and over: A case-control examine. BMC Res Notes. 2019;12(1):1–6. https://doi.org/10.1186/s13104-019-4576-6.

    Article 

    Google Scholar 

  • Gleason LJ, Luque AE, Shah Okay. Polypharmacy within the HIV-infected older grownup inhabitants. Clin Interv Growing older. 2013;8:749–63. https://doi.org/10.2147/CIA.S37738.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Inspecting the associations between HIV-related stigma and well being outcomes in individuals residing with HIV/AIDS: a collection of meta-analyses. BMJ Open. 2016;6(7):e011453.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Osei-yeboah J, Owiredu WKBA, Norgbe GK, Lokpo SY, Obirikorang C, Allotey EA, et al. High quality of Lifetime of Folks Dwelling with HIV / AIDS within the Ho Municipality, Ghana : A Cross-Sectional Research. 2017;2017. https://doi.org/10.1155/2017/6806951.

  • Leave a Reply

    Your email address will not be published. Required fields are marked *